Showing items 1–100
Pyrrolobenzodiazepine-antibody conjugates
Grant US-11813335-B2
United States of America
Site-specific antibody-drug conjugates
Grant US-11702473-B2
United States of America
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
Grant US-11690918-B2
United States of America
Pyrrolobenzodiazepine conjugates
Grant US-11649250-B2
United States of America
Pyrrolobenzodiazepine-antibody conjugates
Grant US-11612665-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-11541047-B2
United States of America
Pyrrolobenzodiazepines and conjugates thereof as antitumour agents
Grant US-11524969-B2
United States of America
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for…
Grant US-11439620-B2
United States of America
TARGETING CONJUGATES COMPRISING EFFECTOR MOLECULES AND USES THEREOF
Application WO-2022179570-A1
World Intellectual Property Organisation (WIPO)
TARGETING CONJUGATES COMPRISING EFFECTOR MOLECULES AND USES THEREOF
Application WO-2022178751-A1
World Intellectual Property Organisation (WIPO)
Pyrrolobenzodiazepine conjugates
Grant US-11370801-B2
United States of America
Methods
Grant US-11352324-B2
United States of America
Dosage regimes for the administration of an anti-CD19 ADC
Grant US-11318211-B2
United States of America
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP…
Grant US-11253606-B2
United States of America
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra…
Grant US-11192955-B2
United States of America
Pyrrolobenzodiazepine-antibody conjugates
Grant US-11160872-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-RE48751-E1
United States of America
Antibody-drug conjugates and uses thereof
Grant US-11116846-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-11077201-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-11066468-B2
United States of America
Humanized anti-AXL antibodies
Grant US-11059893-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-11052156-B2
United States of America
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab…
Grant US-11052081-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-11020489-B2
United States of America
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic…
Grant US-10988539-B2
United States of America
Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes…
Grant US-10954305-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10918721-B2
United States of America
Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab…
Grant US-10918734-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10849986-B2
United States of America
Subcutaneous administration of antibody-drug conjugates for cancer therapy
Grant US-10799597-B2
United States of America
Pyrrolobenzodiazepine conjugates
Grant US-10799595-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10751420-B2
United States of America
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug…
Grant US-10744129-B2
United States of America
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
Grant US-10722594-B2
United States of America
Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR…
Grant US-10709701-B2
United States of America
Charged linkers and their uses for conjugation
Grant US-10696699-B2
United States of America
Charged linkers and their uses for conjugation
Grant US-10696700-B2
United States of America
Charged linkers and their uses for conjugation
Grant US-10683314-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10682347-B2
United States of America
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant US-10662252-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10653793-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-10561738-B2
United States of America
Combination therapy with an anti-axl antibody-drug conjugate
Grant US-10544223-B2
United States of America
Charged linkers and their uses for conjugation
Grant US-10464955-B2
United States of America
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive…
Grant US-10436788-B2
United States of America
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab…
Grant US-10413539-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-10322193-B1
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-10280220-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-10265414-B2
United States of America
Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra…
Grant US-10266605-B2
United States of America
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR…
Grant US-10206918-B2
United States of America
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for…
Grant US-10195175-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10143756-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10137196-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10130718-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10130626-B2
United States of America
Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
Grant US-10131682-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-10064957-B2
United States of America
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic…
Grant US-10058621-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10034950-B2
United States of America
Pyrrolobenzodiazepine—antibody conjugates
Grant US-9956299-B2
United States of America
Humanized anti-CD22 antibody
Grant US-9944703-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9931417-B2
United States of America
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
Grant US-9919056-B2
United States of America
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant US-9879088-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9855344-B2
United States of America
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive…
Grant US-9797907-B2
United States of America
Anti-Trop-2 antibody-drug conjugates and uses thereof
Grant US-9770517-B2
United States of America
Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent…
Grant US-9757458-B2
United States of America
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP…
Grant US-9707302-B2
United States of America
Humanized anti-CD22 antibody
Grant US-9701748-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9700634-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-9675706-B2
United States of America
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant US-9670286-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9629926-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9522959-B2
United States of America
Humanized anti-CD22 antibody
Grant US-9518115-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9499631-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9493574-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-9492566-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9493573-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9480756-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9481732-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9475884-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9458242-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-9388237-B2
United States of America
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant US-9382329-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9375489-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-9345783-B2
United States of America
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
Grant US-9272057-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9233172-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9226973-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9198978-B2
United States of America
Humanized anti-CD22 antibody
Grant US-9139649-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9138485-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Grant US-9133268-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-9107960-B2
United States of America
Immunoconjugates with an intracellularly-cleavable linkage
Application US-9102735-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-9028833-B2
United States of America
Showing items 1–100